npj Genomic Medicine (Mar 2024)

Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib

  • K. M. Ingley,
  • M. Zatzman,
  • A. M. Fontebasso,
  • W. Lo,
  • V. Subasri,
  • A. Goldenberg,
  • Y. Li,
  • S. Davidson,
  • N. Kanwar,
  • L. Waldman,
  • L. Brunga,
  • Y. Babichev,
  • E. G. Demicco,
  • A. Gupta,
  • M. Szybowska,
  • S. Thipphavong,
  • D. Malkin,
  • A. Villani,
  • A. Shlien,
  • R. A. Gladdy,
  • R. H. Kim

DOI
https://doi.org/10.1038/s41525-024-00405-z
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Familial gastrointestinal stromal tumors (GIST) are rare. We present a kindred with multiple family members affected with multifocal GIST who underwent whole genome sequencing of the germline and tumor. Affected individuals with GIST harbored a germline variant found within exon 13 of the KIT gene (c.1965T>G; p.Asn655Lys, p.N655K) and a variant in the MSR1 gene (c.877 C > T; p.Arg293*, pR293X). Multifocal GISTs in the proband and her mother were treated with preoperative imatinib, which resulted in severe intolerance. The clinical features of multifocal GIST, cutaneous mastocytosis, allergies, and gut motility disorders seen in the affected individuals may represent manifestations of the multifunctional roles of KIT in interstitial cells of Cajal or mast cells and/or may be suggestive of additional molecular pathways which can contribute to tumorigenesis.